PHARMECO GROUP OF COMPANIES IS A SPECIAL PARTNER OF THE VI ALL-RUSSIAN GMP CONFERENCE WITH INTERNATIONAL PARTICIPATION
GEDEON RICHTER STARTS PRODUCING IN RUSSIA AN INNOVATIVE DRUG FOR THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER
GMP CONFERENCE ORGANIZERS EXPECTING TO RECEIVE QUESTIONS FROM PHARMACEUTICAL INDUSTRY REPRESENTATIVES RELATED TO TECHNOLOGY TRANSFER
ESTABLISHMENT OF THE SINGLE EAEU MARKET REMAINS ONE OF THE MOST DISCUSSED TOPICS IN THE CONTEXT OF GOOD PRACTICES DEVELOPMENT